Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 329

1.

Role of NKp46+ natural killer cells in house dust mite-driven asthma.

Haspeslagh E, van Helden MJ, Deswarte K, De Prijck S, van Moorleghem J, Boon L, Hammad H, Vivier E, Lambrecht BN.

EMBO Mol Med. 2018 Feb 14. pii: e8657. doi: 10.15252/emmm.201708657. [Epub ahead of print]

2.

A hospital-wide intervention replacing ceftriaxone with cefotaxime to reduce rate of healthcare-associated infections caused by extended-spectrum β-lactamase-producing Enterobacteriaceae in the intensive care unit.

Tan BK, Vivier E, Bouziad KA, Zahar JR, Pommier C, Parmeland L, Pariset C, Misslin P, Haond C, Poirié P, Temime L, Hocine MN.

Intensive Care Med. 2018 Feb 2. doi: 10.1007/s00134-018-5079-y. [Epub ahead of print] No abstract available.

PMID:
29396655
3.

Cardiac function during weaning failure: the role of diastolic dysfunction.

Roche-Campo F, Bedet A, Vivier E, Brochard L, Mekontso Dessap A.

Ann Intensive Care. 2018 Jan 9;8(1):2. doi: 10.1186/s13613-017-0348-4.

4.

A2AR Adenosine Signaling Suppresses Natural Killer Cell Maturation in the Tumor Microenvironment.

Young A, Ngiow SF, Gao Y, Patch AM, Barkauskas DS, Messaoudene M, Lin G, Coudert JD, Stannard KA, Zitvogel L, Degli-Esposti MA, Vivier E, Waddell N, Linden J, Huntington ND, Souza-Fonseca-Guimaraes F, Smyth MJ.

Cancer Res. 2018 Feb 15;78(4):1003-1016. doi: 10.1158/0008-5472.CAN-17-2826. Epub 2017 Dec 11.

PMID:
29229601
5.

ITIMs: episode 1 of the inhibitory saga.

Vivier E.

Nat Rev Immunol. 2018 Jan;18(1):4. doi: 10.1038/nri.2017.134. Epub 2017 Nov 27. No abstract available.

PMID:
29176731
6.

Loss of HIF-1α in natural killer cells inhibits tumour growth by stimulating non-productive angiogenesis.

Krzywinska E, Kantari-Mimoun C, Kerdiles Y, Sobecki M, Isagawa T, Gotthardt D, Castells M, Haubold J, Millien C, Viel T, Tavitian B, Takeda N, Fandrey J, Vivier E, Sexl V, Stockmann C.

Nat Commun. 2017 Nov 17;8(1):1597. doi: 10.1038/s41467-017-01599-w.

7.

Host resistance to endotoxic shock requires the neuroendocrine regulation of group 1 innate lymphoid cells.

Quatrini L, Wieduwild E, Guia S, Bernat C, Glaichenhaus N, Vivier E, Ugolini S.

J Exp Med. 2017 Dec 4;214(12):3531-3541. doi: 10.1084/jem.20171048. Epub 2017 Nov 15.

8.

Editorial: NK Cell Subsets in Health and Disease: New Developments.

Marcenaro E, Notarangelo LD, Orange JS, Vivier E.

Front Immunol. 2017 Oct 18;8:1363. doi: 10.3389/fimmu.2017.01363. eCollection 2017. No abstract available.

9.

Genetic Depletion or Hyperresponsiveness of Natural Killer Cells Do Not Affect Atherosclerosis Development.

Nour-Eldine W, Joffre J, Zibara K, Esposito B, Giraud A, Zeboudj L, Vilar J, Terada M, Bruneval P, Vivier E, Ait-Oufella H, Mallat Z, Ugolini S, Tedgui A.

Circ Res. 2018 Jan 5;122(1):47-57. doi: 10.1161/CIRCRESAHA.117.311743. Epub 2017 Oct 18.

PMID:
29046274
10.

Natural killer cell immunotherapies against cancer: checkpoint inhibitors and more.

Chiossone L, Vienne M, Kerdiles YM, Vivier E.

Semin Immunol. 2017 Jun;31:55-63. doi: 10.1016/j.smim.2017.08.003. Epub 2017 Sep 22. Review.

PMID:
28943093
11.

Determinants of diaphragm thickening fraction during mechanical ventilation: an ancillary study of a randomised trial.

Vivier E, Roche-Campo F, Brochard L, Mekontso Dessap A.

Eur Respir J. 2017 Sep 20;50(3). pii: 1700783. doi: 10.1183/13993003.00783-2017. Print 2017 Sep. No abstract available.

PMID:
28931664
12.

High mTOR activity is a hallmark of reactive natural killer cells and amplifies early signaling through activating receptors.

Marçais A, Marotel M, Degouve S, Koenig A, Fauteux-Daniel S, Drouillard A, Schlums H, Viel S, Besson L, Allatif O, Bléry M, Vivier E, Bryceson Y, Thaunat O, Walzer T.

Elife. 2017 Sep 6;6. pii: e26423. doi: 10.7554/eLife.26423.

13.

Natural-Killer-like B Cells Display the Phenotypic and Functional Characteristics of Conventional B Cells.

Kerdiles YM, Almeida FF, Thompson T, Chopin M, Vienne M, Bruhns P, Huntington ND, Raulet DH, Nutt SL, Belz GT, Vivier E.

Immunity. 2017 Aug 15;47(2):199-200. doi: 10.1016/j.immuni.2017.07.026. No abstract available.

14.

T-bet-dependent NKp46+ innate lymphoid cells regulate the onset of TH17-induced neuroinflammation.

Kwong B, Rua R, Gao Y, Flickinger J Jr, Wang Y, Kruhlak MJ, Zhu J, Vivier E, McGavern DB, Lazarevic V.

Nat Immunol. 2017 Oct;18(10):1117-1127. doi: 10.1038/ni.3816. Epub 2017 Aug 14.

15.

Innate lymphoid cells: major players in inflammatory diseases.

Ebbo M, Crinier A, Vély F, Vivier E.

Nat Rev Immunol. 2017 Nov;17(11):665-678. doi: 10.1038/nri.2017.86. Epub 2017 Aug 14. Review.

PMID:
28804130
16.

Tumor immunoevasion by the conversion of effector NK cells into type 1 innate lymphoid cells.

Gao Y, Souza-Fonseca-Guimaraes F, Bald T, Ng SS, Young A, Ngiow SF, Rautela J, Straube J, Waddell N, Blake SJ, Yan J, Bartholin L, Lee JS, Vivier E, Takeda K, Messaoudene M, Zitvogel L, Teng MWL, Belz GT, Engwerda CR, Huntington ND, Nakamura K, Hölzel M, Smyth MJ.

Nat Immunol. 2017 Sep;18(9):1004-1015. doi: 10.1038/ni.3800. Epub 2017 Jul 31.

PMID:
28759001
17.

[Innate lymphoid cells].

Crinier A, Viant C, Girard-Madoux M, Vivier É.

Med Sci (Paris). 2017 May;33(5):534-542. doi: 10.1051/medsci/20173305018. Epub 2017 Jun 14. French.

PMID:
28612730
18.

The Abl-1 Kinase is Dispensable for NK Cell Inhibitory Signalling and is not Involved in Murine NK Cell Education.

Ganesan S, Luu TT, Chambers BJ, Meinke S, Brodin P, Vivier E, Wetzel DM, Koleske AJ, Kadri N, Höglund P.

Scand J Immunol. 2017 Sep;86(3):135-142. doi: 10.1111/sji.12574.

PMID:
28605050
19.

Shifting the Balance of Activating and Inhibitory Natural Killer Receptor Ligands on BRAFV600E Melanoma Lines with Vemurafenib.

Frazao A, Colombo M, Fourmentraux-Neves E, Messaoudene M, Rusakiewicz S, Zitvogel L, Vivier E, Vély F, Faure F, Dréno B, Benlalam H, Bouquet F, Savina A, Pasmant E, Toubert A, Avril MF, Caignard A.

Cancer Immunol Res. 2017 Jul;5(7):582-593. doi: 10.1158/2326-6066.CIR-16-0380. Epub 2017 Jun 2.

PMID:
28576831
20.

Immune checkpoints on innate lymphoid cells.

Chiossone L, Vivier E.

J Exp Med. 2017 Jun 5;214(6):1561-1563. doi: 10.1084/jem.20170763. Epub 2017 May 17.

21.

Complement factor P is a ligand for the natural killer cell-activating receptor NKp46.

Narni-Mancinelli E, Gauthier L, Baratin M, Guia S, Fenis A, Deghmane AE, Rossi B, Fourquet P, Escalière B, Kerdiles YM, Ugolini S, Taha MK, Vivier E.

Sci Immunol. 2017 Apr 28;2(10). pii: eaam9628. doi: 10.1126/sciimmunol.aam9628.

22.

Inherited GINS1 deficiency underlies growth retardation along with neutropenia and NK cell deficiency.

Cottineau J, Kottemann MC, Lach FP, Kang YH, Vély F, Deenick EK, Lazarov T, Gineau L, Wang Y, Farina A, Chansel M, Lorenzo L, Piperoglou C, Ma CS, Nitschke P, Belkadi A, Itan Y, Boisson B, Jabot-Hanin F, Picard C, Bustamante J, Eidenschenk C, Boucherit S, Aladjidi N, Lacombe D, Barat P, Qasim W, Hurst JA, Pollard AJ, Uhlig HH, Fieschi C, Michon J, Bermudez VP, Abel L, de Villartay JP, Geissmann F, Tangye SG, Hurwitz J, Vivier E, Casanova JL, Smogorzewska A, Jouanguy E.

J Clin Invest. 2017 May 1;127(5):1991-2006. doi: 10.1172/JCI90727. Epub 2017 Apr 17.

23.

FHL2 Regulates Natural Killer Cell Development and Activation during Streptococcus pneumoniae Infection.

Baranek T, Morello E, Valayer A, Aimar RF, Bréa D, Henry C, Besnard AG, Dalloneau E, Guillon A, Dequin PF, Narni-Mancinelli E, Vivier E, Laurent F, Wei Y, Paget C, Si-Tahar M.

Front Immunol. 2017 Feb 13;8:123. doi: 10.3389/fimmu.2017.00123. eCollection 2017.

24.

The discontinuity theory of immunity.

Pradeu T, Vivier E.

Sci Immunol. 2016 Jul 14;1(1). pii: AAG0479. doi: 10.1126/sciimmunol.aag0479.

25.

Killer ILCs in the Fat.

Narni-Mancinelli E, Vivier E.

Immunity. 2017 Feb 21;46(2):169-171. doi: 10.1016/j.immuni.2017.02.004.

PMID:
28228274
26.

NKp30 isoforms and NKp30 ligands are predictive biomarkers of response to imatinib mesylate in metastatic GIST patients.

Rusakiewicz S, Perier A, Semeraro M, Pitt JM, Pogge von Strandmann E, Reiners KS, Aspeslagh S, Pipéroglou C, Vély F, Ivagnes A, Jegou S, Halama N, Chaigneau L, Validire P, Christidis C, Perniceni T, Landi B, Berger A, Isambert N, Domont J, Bonvalot S, Terrier P, Adam J, Coindre JM, Emile JF, Poirier-Colame V, Chaba K, Rocha B, Caignard A, Toubert A, Enot D, Koch J, Marabelle A, Lambert M, Caillat-Zucman S, Leyvraz S, Auclair C, Vivier E, Eggermont A, Borg C, Blay JY, Le Cesne A, Mir O, Zitvogel L.

Oncoimmunology. 2016 Apr 25;6(1):e1137418. doi: 10.1080/2162402X.2015.1137418. eCollection 2017.

27.

Cell cycle progression dictates the requirement for BCL2 in natural killer cell survival.

Viant C, Guia S, Hennessy RJ, Rautela J, Pham K, Bernat C, Goh W, Jiao Y, Delconte R, Roger M, Simon V, Souza-Fonseca-Guimaraes F, Grabow S, Belz GT, Kile BT, Strasser A, Gray D, Hodgkin PD, Beutler B, Vivier E, Ugolini S, Huntington ND.

J Exp Med. 2017 Feb;214(2):491-510. doi: 10.1084/jem.20160869. Epub 2017 Jan 5.

28.

Trans-inhibition of activation and proliferation signals by Fc receptors in mast cells and basophils.

Malbec O, Cassard L, Albanesi M, Jönsson F, Mancardi D, Chicanne G, Payrastre B, Dubreuil P, Vivier E, Daëron M.

Sci Signal. 2016 Dec 20;9(459):ra126. doi: 10.1126/scisignal.aag1401.

PMID:
27999175
29.

Manufacturing Natural Killer Cells as Medicinal Products.

Chabannon C, Mfarrej B, Guia S, Ugolini S, Devillier R, Blaise D, Vivier E, Calmels B.

Front Immunol. 2016 Nov 15;7:504. eCollection 2016. Review.

30.

Corrigendum: Evidence of innate lymphoid cell redundancy in humans.

Vély F, Barlogis V, Vallentin B, Neven B, Piperoglou C, Perchet T, Petit M, Yessaad N, Touzot F, Bruneau J, Mahlaoui N, Zucchini N, Farnarier C, Michel G, Moshous D, Blanche S, Dujardin A, Spits H, Distler JH, Ramming A, Picard C, Golub R, Fischer A, Vivier E.

Nat Immunol. 2016 Nov 16;17(12):1479. doi: 10.1038/ni1216-1479b. No abstract available.

PMID:
27849206
31.

Structural Insights into the Inhibitory Mechanism of an Antibody against B7-H6, a Stress-Induced Cellular Ligand for the Natural Killer Cell Receptor NKp30.

Xu X, Narni-Mancinelli E, Cantoni C, Li Y, Guia S, Gauthier L, Chen Q, Moretta A, Vély F, Eisenstein E, Rangarajan S, Vivier E, Mariuzza RA.

J Mol Biol. 2016 Nov 6;428(22):4457-4466. doi: 10.1016/j.jmb.2016.09.011. Epub 2016 Sep 20.

PMID:
27663271
32.

Evidence of innate lymphoid cell redundancy in humans.

Vély F, Barlogis V, Vallentin B, Neven B, Piperoglou C, Ebbo M, Perchet T, Petit M, Yessaad N, Touzot F, Bruneau J, Mahlaoui N, Zucchini N, Farnarier C, Michel G, Moshous D, Blanche S, Dujardin A, Spits H, Distler JH, Ramming A, Picard C, Golub R, Fischer A, Vivier E.

Nat Immunol. 2016 Nov;17(11):1291-1299. doi: 10.1038/ni.3553. Epub 2016 Sep 12. Erratum in: Nat Immunol. 2016 Nov 16;17 (12 ):1479.

33.

PD-1 mediates functional exhaustion of activated NK cells in patients with Kaposi sarcoma.

Beldi-Ferchiou A, Lambert M, Dogniaux S, Vély F, Vivier E, Olive D, Dupuy S, Levasseur F, Zucman D, Lebbé C, Sène D, Hivroz C, Caillat-Zucman S.

Oncotarget. 2016 Nov 8;7(45):72961-72977. doi: 10.18632/oncotarget.12150.

34.

HLA-Fatal attraction.

Vély F, Golub R, Vivier E.

Nat Immunol. 2016 Aug 19;17(9):1012-4. doi: 10.1038/ni.3541. No abstract available.

PMID:
27540985
35.

The evolution of innate lymphoid cells.

Vivier E, van de Pavert SA, Cooper MD, Belz GT.

Nat Immunol. 2016 Jun 21;17(7):790-4. doi: 10.1038/ni.3459.

36.

Since their identification 40 years ago, natural killer (NK) cells write a never-ending story. Introduction.

Vivier E, Di Santo J, Moretta A.

Curr Top Microbiol Immunol. 2016;395:v-vi. No abstract available.

PMID:
27222904
37.

Low Circulating Natural Killer Cell Counts are Associated With Severe Disease in Patients With Common Variable Immunodeficiency.

Ebbo M, Gérard L, Carpentier S, Vély F, Cypowyj S, Farnarier C, Vince N, Malphettes M, Fieschi C, Oksenhendler E, Schleinitz N, Vivier E; DEFI Study Group.

EBioMedicine. 2016 Apr;6:222-230. doi: 10.1016/j.ebiom.2016.02.025. Epub 2016 Mar 2.

38.

Transforming Growth Factor-β Signaling Guides the Differentiation of Innate Lymphoid Cells in Salivary Glands.

Cortez VS, Cervantes-Barragan L, Robinette ML, Bando JK, Wang Y, Geiger TL, Gilfillan S, Fuchs A, Vivier E, Sun JC, Cella M, Colonna M.

Immunity. 2016 May 17;44(5):1127-39. doi: 10.1016/j.immuni.2016.03.007. Epub 2016 May 3.

39.

Transforming growth factor-β and Notch ligands act as opposing environmental cues in regulating the plasticity of type 3 innate lymphoid cells.

Viant C, Rankin LC, Girard-Madoux MJ, Seillet C, Shi W, Smyth MJ, Bartholin L, Walzer T, Huntington ND, Vivier E, Belz GT.

Sci Signal. 2016 May 3;9(426):ra46. doi: 10.1126/scisignal.aaf2176.

PMID:
27141930
40.

Science Signaling Podcast for 3 May 2016: Innate lymphoid cell plasticity.

Vivier E, Golub R, VanHook AM.

Sci Signal. 2016 May 3;9(426):pc10. doi: 10.1126/scisignal.aaf9126.

PMID:
27141927
41.

Immunodynamics: a cancer immunotherapy trials network review of immune monitoring in immuno-oncology clinical trials.

Kohrt HE, Tumeh PC, Benson D, Bhardwaj N, Brody J, Formenti S, Fox BA, Galon J, June CH, Kalos M, Kirsch I, Kleen T, Kroemer G, Lanier L, Levy R, Lyerly HK, Maecker H, Marabelle A, Melenhorst J, Miller J, Melero I, Odunsi K, Palucka K, Peoples G, Ribas A, Robins H, Robinson W, Serafini T, Sondel P, Vivier E, Weber J, Wolchok J, Zitvogel L, Disis ML, Cheever MA; Cancer Immunotherapy Trials Network (CITN).

J Immunother Cancer. 2016 Mar 15;4:15. doi: 10.1186/s40425-016-0118-0. eCollection 2016. Review.

42.

[Innate Lymphoid Cells: new actors of immunity].

Cypowyj S, Vivier É.

Bull Acad Natl Med. 2016 Mar;200(3):561-72; discussion 573-4. Review. French.

PMID:
28644604
43.

Murine peripheral NK-cell populations originate from site-specific immature NK cells more than from BM-derived NK cells.

Pinhas N, Sternberg-Simon M, Chiossone L, Shahaf G, Walzer T, Vivier E, Mehr R.

Eur J Immunol. 2016 May;46(5):1258-70. doi: 10.1002/eji.201545847. Epub 2016 Mar 31.

44.

NLRC5 shields T lymphocytes from NK-cell-mediated elimination under inflammatory conditions.

Ludigs K, Jandus C, Utzschneider DT, Staehli F, Bessoles S, Dang AT, Rota G, Castro W, Zehn D, Vivier E, Held W, Romero P, Guarda G.

Nat Commun. 2016 Feb 10;7:10554. doi: 10.1038/ncomms10554.

45.

The Helix-Loop-Helix Protein ID2 Governs NK Cell Fate by Tuning Their Sensitivity to Interleukin-15.

Delconte RB, Shi W, Sathe P, Ushiki T, Seillet C, Minnich M, Kolesnik TB, Rankin LC, Mielke LA, Zhang JG, Busslinger M, Smyth MJ, Hutchinson DS, Nutt SL, Nicholson SE, Alexander WS, Corcoran LM, Vivier E, Belz GT, Carotta S, Huntington ND.

Immunity. 2016 Jan 19;44(1):103-115. doi: 10.1016/j.immuni.2015.12.007. Epub 2016 Jan 12.

46.

Cutting Edge: Eomesodermin Is Sufficient To Direct Type 1 Innate Lymphocyte Development into the Conventional NK Lineage.

Pikovskaya O, Chaix J, Rothman NJ, Collins A, Chen YH, Scipioni AM, Vivier E, Reiner SL.

J Immunol. 2016 Feb 15;196(4):1449-54. doi: 10.4049/jimmunol.1502396. Epub 2016 Jan 20.

47.

NK Cell-Specific Gata3 Ablation Identifies the Maturation Program Required for Bone Marrow Exit and Control of Proliferation.

Ali AK, Oh JS, Vivier E, Busslinger M, Lee SH.

J Immunol. 2016 Feb 15;196(4):1753-67. doi: 10.4049/jimmunol.1501593. Epub 2016 Jan 15.

48.

Editorial overview: Innate immunity.

Vivier E, Medzhitov R.

Curr Opin Immunol. 2016 Feb;38:v-vii. doi: 10.1016/j.coi.2015.12.005. Epub 2015 Dec 28. No abstract available.

PMID:
26739338
49.

Innate lymphoid cells: parallel checkpoints and coordinate interactions with T cells.

Huntington ND, Carpentier S, Vivier E, Belz GT.

Curr Opin Immunol. 2016 Feb;38:86-93. doi: 10.1016/j.coi.2015.11.008. Epub 2015 Dec 29. Review.

PMID:
26736074
50.

Complementarity and redundancy of IL-22-producing innate lymphoid cells.

Rankin LC, Girard-Madoux MJ, Seillet C, Mielke LA, Kerdiles Y, Fenis A, Wieduwild E, Putoczki T, Mondot S, Lantz O, Demon D, Papenfuss AT, Smyth GK, Lamkanfi M, Carotta S, Renauld JC, Shi W, Carpentier S, Soos T, Arendt C, Ugolini S, Huntington ND, Belz GT, Vivier E.

Nat Immunol. 2016 Feb;17(2):179-86. doi: 10.1038/ni.3332. Epub 2015 Nov 30.

Supplemental Content

Loading ...
Support Center